Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 292,465 | 224,617 | 193,252 | 177,668 | 165,166 |
| Marketable Securities | 210,966 | 231,882 | N/A | N/A | 5,377 |
| Receivables | 160,707 | 172,486 | 167,450 | N/A | 89,646 |
| Inventories | 35,247 | 27,192 | 16,436 | 9,807 | 7,668 |
| Other current assets | 5,607 | 5,528 | 6,367 | 146,956 | 3,137 |
| TOTAL | $726,920 | $675,860 | $395,183 | $343,009 | $276,375 |
| Non-Current Assets | |||||
| PPE Net | 10,647 | 10,320 | 6,832 | 5,840 | 5,857 |
| Intangibles | 3,563 | 3,563 | 3,563 | 3,563 | 3,563 |
| Other Non-Current Assets | 62,603 | 66,868 | 60,961 | 56,515 | 41,588 |
| TOTAL | $76,813 | $80,751 | $71,356 | $65,918 | $51,008 |
| Total Assets | $803,733 | $756,611 | $466,539 | $408,927 | $327,383 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,990 | 21,179 | 20,485 | 25,985 | 13,709 |
| Accrued Expenses | 116,819 | 104,958 | 96,077 | 86,788 | 66,947 |
| Other current liabilities | 4,623 | 3,626 | 2,449 | 2,196 | 2,045 |
| TOTAL | $133,432 | $129,763 | $119,011 | $114,969 | $82,701 |
| Non-Current Liabilities | |||||
| Long Term Debt | 74,267 | 74,059 | 73,858 | 73,663 | 73,472 |
| Other Non-Current Liabilities | 340,303 | 339,412 | 116,395 | 115,081 | 115,187 |
| TOTAL | $414,570 | $413,471 | $190,253 | $188,744 | $188,659 |
| Total Liabilities | $548,002 | $543,234 | $309,264 | $303,713 | $271,360 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,048 | 71,470 | 70,913 | 70,624 | 70,129 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -772,462 | -800,395 | -859,426 | -894,998 | -934,225 |
| Other shareholders' equity | -255 | -257 | 50 | -558 | -452 |
| TOTAL | $255,731 | $213,377 | $157,275 | $105,214 | $56,023 |
| Total Liabilities And Equity | $803,733 | $756,611 | $466,539 | $408,927 | $327,383 |